Floatz logo

ERGOCALCIFEROLUM

Burn Injury

University of North Carolina, Chapel HillSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Burn Injury cohort.

Asset / SponsorPhaseRating
Oliceridine
University of Tennessee
Phase 4BB
FENTANYL
Cephalon
Phase 2B
TESTOSTERONE UNDECYLATE
National Center for Research Resources (NCRR)
N/AD

Same molecule, other indications

ERGOCALCIFEROLUM is also rated in:

vitamin D deficiencyDormant
BB
Indicative ·
64 / 100
View asset →
secondary hyperparathyroidismDormant
BB
Indicative ·
64 / 100
View asset →
cholestasisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →